Skip to main content
Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis.
Clinical trials for pediatric MS should be prioritized to test only one or two of the most promising agents - NO.
Sex differences and subclinical retinal injury in pediatric-onset MS.
Genetic predictors of relapse rate in pediatric MS.
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.
Neuropsychological correlates of multiple sclerosis across the lifespan.
Menarche increases relapse risk in pediatric multiple sclerosis.
Impact of parental multiple sclerosis on early childhood development: A retrospective cohort study.
Copy number variation in pediatric multiple sclerosis.
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.